These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The effects of scopolamine on changes in regional cerebral blood flow during classical conditioning of the human eyeblink response. Bahro M; Molchan SE; Sunderland T; Herscovitch P; Schreurs BG Neuropsychobiology; 1999 May; 39(4):187-95. PubMed ID: 10343183 [TBL] [Abstract][Full Text] [Related]
23. Age-related changes in muscarinic cholinergic receptors in the living brain: a PET study using N-[11C]methyl-4-piperidyl benzilate combined with cerebral blood flow measurement in conscious monkeys. Kakiuchi T; Ohba H; Nishiyama S; Sato K; Harada N; Nakanishi S; Tsukada H Brain Res; 2001 Oct; 916(1-2):22-31. PubMed ID: 11597587 [TBL] [Abstract][Full Text] [Related]
24. Imaging mitochondrial complex I activation during a vibrotactile stimulation: A PET study using [ Fang J; Ohba H; Hashimoto F; Tsukada H; Chen F; Liu H J Cereb Blood Flow Metab; 2020 Dec; 40(12):2521-2532. PubMed ID: 31948325 [TBL] [Abstract][Full Text] [Related]
25. Quantitative PET analysis of regional cerebral blood flow and glucose and oxygen metabolism in response to fenfluramine in living porcine brain. Smith DF; Poulsen PH; Ishizu K; Sakoh M; Hansen SB; Gee AD; Bender D; Gjedde A J Neurosci Methods; 1998 Dec; 86(1):17-23. PubMed ID: 9894782 [TBL] [Abstract][Full Text] [Related]
26. Comparison of cholinergic drug effects on regional brain glucose consumption in rats and humans by means of autoradiography and position emission tomography. Blin J; Ray CA; Piercey MF; Bartko JJ; Mouradian MM; Chase TN Brain Res; 1994 Jan; 635(1-2):196-202. PubMed ID: 8173955 [TBL] [Abstract][Full Text] [Related]
27. Neuronal nitric oxide has a role as a perfusion regulator and a synaptic modulator in cerebellum but not in neocortex during somatosensory stimulation--an animal PET study. Hayashi T; Katsumi Y; Mukai T; Inoue M; Nagahama Y; Oyanagi C; Yamauchi H; Shibasaki H; Fukuyama H Neurosci Res; 2002 Oct; 44(2):155-65. PubMed ID: 12354630 [TBL] [Abstract][Full Text] [Related]
28. The cyclooxygenase inhibitors indomethacin and Rofecoxib reduce regional cerebral blood flow evoked by somatosensory stimulation in rats. Bakalova R; Matsuura T; Kanno I Exp Biol Med (Maywood); 2002 Jul; 227(7):465-73. PubMed ID: 12094010 [TBL] [Abstract][Full Text] [Related]
29. Altered neural cholinergic receptor systems in cocaine-addicted subjects. Adinoff B; Devous MD; Williams MJ; Best SE; Harris TS; Minhajuddin A; Zielinski T; Cullum M Neuropsychopharmacology; 2010 Jun; 35(7):1485-99. PubMed ID: 20393457 [TBL] [Abstract][Full Text] [Related]
30. A PET study after treatment with an anxiety-provoking agent, m-chlorophenyl-piperazine, in conscious rhesus monkeys. Takamatsu H; Noda A; Murakami Y; Tatsumi M; Ichise R; Nishimura S J Nucl Med; 2003 Sep; 44(9):1516-21. PubMed ID: 12960201 [TBL] [Abstract][Full Text] [Related]
31. Competitive antagonists and partial agonists at the glycine modulatory site of the mouse N-methyl-D-aspartate receptor. Henderson G; Johnson JW; Ascher P J Physiol; 1990 Nov; 430():189-212. PubMed ID: 1707965 [TBL] [Abstract][Full Text] [Related]
32. A PET study following treatment with a pharmacological stressor, FG7142, in conscious rhesus monkeys. Takamatsu H; Noda A; Kurumaji A; Murakami Y; Tatsumi M; Ichise R; Nishimura S Brain Res; 2003 Aug; 980(2):275-80. PubMed ID: 12867268 [TBL] [Abstract][Full Text] [Related]
33. Positron emission tomography studies of the somatosensory system in man. Roland PE; Seitz RJ Ciba Found Symp; 1991; 163():113-20; discussion 120-4. PubMed ID: 1815888 [TBL] [Abstract][Full Text] [Related]
34. Prolonged effects of cholinesterase inhibition with eptastigmine on the cerebral blood flow-metabolism ratio of normal rats. Scremin OU; Scremin AM; Heuser D; Hudgell R; Romero E; Imbimbo BP J Cereb Blood Flow Metab; 1993 Jul; 13(4):702-11. PubMed ID: 8314923 [TBL] [Abstract][Full Text] [Related]
35. Effect of cervical spinal cord stimulation (cSCS) on cerebral glucose metabolism and blood flow in a vegetative patient assessed by positron emission tomography (PET) and single photon emission computed tomography (SPECT). Momose T; Matsui T; Kosaka N; Ohtake T; Watanabe T; Nishikawa J; Abe K; Tanaka J; Takakura K; Iio M Radiat Med; 1989; 7(5):243-6. PubMed ID: 2629037 [TBL] [Abstract][Full Text] [Related]
36. Effects of NMDA modulation in scopolamine dementia. Jones RW; Wesnes KA; Kirby J Ann N Y Acad Sci; 1991; 640():241-4. PubMed ID: 1837979 [TBL] [Abstract][Full Text] [Related]
37. Comparison of regional cerebral blood flow and glucose metabolism in the normal brain: effect of aging. Bentourkia M; Bol A; Ivanoiu A; Labar D; Sibomana M; Coppens A; Michel C; Cosnard G; De Volder AG J Neurol Sci; 2000 Dec; 181(1-2):19-28. PubMed ID: 11099707 [TBL] [Abstract][Full Text] [Related]
38. d-Cycloserine reverses scopolamine-induced object and place memory deficits in a spontaneous recognition paradigm in rats. Ozawa T; Yamada K; Ichitani Y Pharmacol Biochem Behav; 2019 Dec; 187():172798. PubMed ID: 31678790 [TBL] [Abstract][Full Text] [Related]